OMCL vs VEEV

For growth investors, Veeva Systems Inc.

(VEEV) is the stronger pick with 16. 3% revenue growth year-over-year, versus 6. 5% for Omnicell, Inc. (OMCL). Veeva Systems Inc. (VEEV) offers the better valuation at 30. 9x trailing P/E (19. 0x forward), making it the more compelling value choice. Analysts rate Veeva Systems Inc. (VEEV) a "Buy" — based on 42 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Veeva Systems Inc.

(VEEV) is the cheapest at 30. 9x versus Omnicell, Inc. at 978. 1x. On forward P/E, Veeva Systems Inc. is actually cheaper at 19. 0x.

Over the past 5 years, Veeva Systems Inc.

(VEEV) delivered a total return of -35. 3%, compared to -69. 4% for Omnicell, Inc. (OMCL). Over 10 years, the gap is even starker: VEEV returned +519. 4% versus OMCL's +36. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Veeva Systems Inc.

(VEEV) is the lower-risk stock at 0. 77β versus Omnicell, Inc. 's 1. 34β — meaning OMCL is approximately 73% more volatile than VEEV relative to the S&P 500. On balance sheet safety, Veeva Systems Inc. (VEEV) carries a lower debt/equity ratio of 1% versus 17% for Omnicell, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Veeva Systems Inc.

(VEEV) is pulling ahead at 16. 3% versus 6. 5% for Omnicell, Inc. (OMCL). On earnings-per-share growth, the picture is similar: Veeva Systems Inc. grew EPS 25. 9% year-over-year, compared to -83. 6% for Omnicell, Inc.. Over a 3-year CAGR, VEEV leads at 14. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Veeva Systems Inc.

(VEEV) is the more profitable company, earning 28. 4% net margin versus 0. 2% for Omnicell, Inc. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VEEV leads at 28. 7% versus 0. 4% for OMCL. At the gross margin level — before operating expenses — VEEV leads at 75. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Veeva Systems Inc.

(VEEV) trades at 19. 0x forward P/E versus 22. 4x for Omnicell, Inc. — 3. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for VEEV: 66. 5% to $280. 10.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Veeva Systems Inc.

(VEEV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 77), +519. 4% 10Y return). Both have compounded well over 10 years (VEEV: +519. 4%, OMCL: +36. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: OMCL is a small-cap quality compounder stock; VEEV is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.